Hypofractionated stereotactic radiotherapy as a salvage therapy for recurrent high-grade gliomas

被引：0
|
作者：
Reynaud, T. [1 ]
Vulquin, N. [1 ]
Farah, W. [2 ]
Thibouw, D. [1 ]
Crehange, G. [1 ]
Bertaut, A. [3 ]
Truc, G. [1 ]
机构：
[1] Ctr Georges Francois Leclerc, Radiotherapy, Dijon, France
[2] CHU, Neurosurg, Dijon, France
[3] Ctr Georges Francois Leclerc, Epidemiol & Biostat, Dijon, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31509-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1199
引用
下载
收藏
页码：S669 / S669
页数：1
相关论文
共 50 条
  • [21] The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas
    Meral Y. Sayin
    Bektas Kaya
    Bekir H. Bakkal
    Kadri Altundag
    Muzaffer B. Altundag
    Medical Oncology, 2007, 24 : 379 - 383
  • [22] The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas
    Sayin, Meral Y.
    Kaya, Bektas
    Bakkal, Bekir H.
    Altundag, Kadri
    Altundag, Muzaffer B.
    MEDICAL ONCOLOGY, 2007, 24 (04) : 379 - 383
  • [23] Salvage therapy with bevacizumab and chemotherapy (irinotecan or fotemustine) in recurrent high-grade gliomas
    Trevisan, E.
    Laguzzi, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Bazzoli, E.
    Guarneri, D.
    Soffietti, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S53 - S53
  • [24] Re-Irradiation with high-dose stereotactic radiotherapy for recurrent High-grade Gliomas
    Mousli, A.
    Bocquet, V.
    Frederick, B.
    Louis, C.
    Biver, S.
    Philippi, S.
    Nickers, P.
    Untereiner, M.
    Vogin, G.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S864 - S864
  • [25] Patterns of Failure Following Concurrent Bevacizumab and Hypofractionated Stereotactic Radiotherapy for Recurrent High-grade Glioma
    Shapiro, L. Q.
    Karimi, S.
    Gutin, P. H.
    Iwamoto, F. M.
    Zhang, Z.
    Lassman, A. B.
    Abrey, L. E.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S125 - S125
  • [26] Survival Following Stereotactic Radiotherapy for Recurrent High Grade Gliomas
    Ertas, Gulcin
    Ucer, Ali R.
    Guney, Yildiz Y.
    Avci, Gulhan G.
    Altundag, M. Bedri
    Abanuz, Hayati
    Demirkasimoglu, Atilla
    Calikoglu, Tamer
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (04): : 233 - 238
  • [27] RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
    Nishimoto, Shota
    Kawanishi, Yu
    Fujita, Shohei
    Yawata, Toshio
    Ueba, Tetsuya
    NEURO-ONCOLOGY, 2020, 22 : 459 - 459
  • [28] Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
    Sari, Sezin Yuce
    Aktas, Burak Yasin
    Kertmen, Neyran
    Elmali, Aysenur
    Kilickap, Sadettin
    Oguz, Kader Karli
    Mut, Melike
    Erman, Mustafa
    Soylemezoglu, Figen
    Zorlu, Faruk
    Yazici, Gozde
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [29] Radiosurgery vs. hypofractionated stereotactic radiotherapy in patients with high grade gliomas
    Villa, S.
    Lucas, A.
    Navarro, V.
    Gil, M.
    Bruna, J.
    Linero, D.
    Majos, C.
    Acebes, J. J.
    Vila, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 139 - 139
  • [30] A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY WITH SUNITINIB IN RECURRENT HIGH-GRADE GLIOMA
    Wuthrick, Evan
    Curran, Walter
    Lin, Alexander
    Glass, Jon
    Evans, James
    Andrews, David
    Axelrod, Rita
    Pereira-Rico, Alvaro
    Murphy, Heather
    Werner-Wasik, Maria
    Dicker, Adam
    NEURO-ONCOLOGY, 2008, 10 (05) : 885 - 885
12345